Tonix Pharmaceuticals Holding (TNXP) Operating Expenses (2023 - 2025)
Historic Operating Expenses for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to $36.4 million.
- Tonix Pharmaceuticals Holding's Operating Expenses rose 9785.05% to $36.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $110.2 million, marking a year-over-year decrease of 2790.15%. This contributed to the annual value of $146.8 million for FY2024, which is 1636.73% up from last year.
- Tonix Pharmaceuticals Holding's Operating Expenses amounted to $36.4 million in Q3 2025, which was up 9785.05% from $30.3 million recorded in Q2 2025.
- Tonix Pharmaceuticals Holding's Operating Expenses' 5-year high stood at $79.5 million during Q2 2024, with a 5-year trough of $18.4 million in Q3 2024.
- Moreover, its 3-year median value for Operating Expenses was $30.3 million (2025), whereas its average is $32.8 million.
- Examining YoY changes over the last 5 years, Tonix Pharmaceuticals Holding's Operating Expenses showed a top increase of 9785.05% in 2025 and a maximum decrease of 6190.58% in 2025.
- Over the past 3 years, Tonix Pharmaceuticals Holding's Operating Expenses (Quarter) stood at $31.1 million in 2023, then fell by 19.44% to $25.1 million in 2024, then surged by 45.07% to $36.4 million in 2025.
- Its Operating Expenses was $36.4 million in Q3 2025, compared to $30.3 million in Q2 2025 and $18.5 million in Q1 2025.